Dopaminergic D1 receptor agonist SKF 38393 induces GAP-43 expression and long-term potentiation in hippocampus in vivo

Neuroscience Letters

Volumn 402, Issue 1-2, 2006, Pages 46-50

  Williams, Shimere ^a   Mmbaga, Natu ^a   Chirwa, Sanika ^a,b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Dopamine D1 receptors; Growth associated protein 43; Hippocampus; Long term potentiation

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR AFFECTING AGENT; NEUROMODULIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; EXPERIMENTAL MODEL; HIPPOCAMPUS; IN VIVO STUDY; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; GENE EXPRESSION; GUINEA PIG; MALE; METABOLISM; METHODOLOGY; RAT; WESTERN BLOTTING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; GAP-43 PROTEIN; GENE EXPRESSION; GUINEA PIGS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; RATS;

EID: 33646761986     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.03.075     Document Type: Article

References (24)

1. Andersen P., Bliss T.V.P., and Skrede K.K. Unit analysis of hippocampal population spikes. Exp. Brain Res. 13 (1971) 208-221
2. Andersen P., Sundberg S.H., Sveen O., Swann J.W., and Wigstrom H. Possible mechanisms for long-lasting potentiation of synaptic transmission in hippocampal slices from guinea pigs. J. Physiol. (Lond.) 302 (1980) 463-482
3. Benowitz L.I., and Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. TINS 20 (1997) 84-91
4. Bliss T.V.P., and Collingridge G. A synaptic model of memory and long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
5. Cantallops I., and Routtenberg A. Activity-dependent regulation of axonal growth: posttranscriptional control of the GAP-43 gene by the NMDA receptor in developing hippocampus. J. Neurobiol. 41 (1999) 208-220
6. 1 signaling couples growth associated protein-43 and long-term potentiation in guinea pig hippocampus. Brain Res. Bull. 64 (2005) 433-440
7. Davis S., Bliss T.V.P., Dutrieux G., Laroche S., and Errington M.L. Induction and duration of long-term potentiation in the hippocampus of the freely moving mouse. J. Neurosci. Methods 75 (1997) 75-80
8. Frey U., Krug M., Reymann K.G., Matthies H., and Anisomycin. An inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res. 452 (1988) 57-65
9. 1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro. Neurosci. Lett. 129 (1991) 1661-1664
10. Frey U., and Morris R.G. Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci. 21 (1998) 181-188
11. Frey U., Schroeder H., and Matthies H. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Res. 522 (1990) 69-75
12. 5 receptor agonists induce a protein synthesis dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2446-2450
13. Irwin N., Chao S., Goritchenko L., Horiuchi A., Greengard P., Nairn A.C., and Benowitz L.I. Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19. PNAS 99 (2002) 12427-12431
14. Lu Y.M., Mansuy I.M., Kandel E.R., and Roder J. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron 26 (2000) 197-205
15. 1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. Neuroreport 8 (1997) 3533-3535
16. Mockett B.G., Brooks W.M., Tate W.P., and Abraham W.C. Dopamine D1/D5 receptor activation fails to initiate an activity-independent late-phase LTP in rat hippocampus. Brain Res. 1021 (2004) 92-100
17. Nakanishi K., Saito H., and Abe K. The supramammilary nucleus contributes to associative EPSP-spike potentiation in the rat dentate gyrus in vivo. Eur. J. Neurosci. 13 (2001) 793-800
18. Namgung U., Matsuyama S., and Routtenberg A. Long-term potentiation activates the GAP-43 promoter: selective participation of hippocampal mossy cells. PNAS 94 (1997) 11675-11680
19. Nedivi E., Basi G.S., Akey I.V., and Skene J.H.P. A neural-specific GAP-43 core promoter located between unusual DNA elements that regulate its activity. J. Neurosci. 12 (2000) 691-704
20. Oestreicher A.B., De Graan P.N.E., Gispen W.H., Verhaagen J., and Scrama L.H. B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog. Neurobiol. 53 (1997) 627-686
21. Sanes J.R., and Lichtman J.W. Can molecules explain long-term potentiation?. Nat. Neurosci. 2 (1999) 597-604
22. Seeman P., and Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15 (1994) 264-270
23. 5 receptor and β-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience 92 (1999) 485-497
24. Sweatt J.D. Mechanisms of Memory (2003), Elsevier, San Diego 400 pp.